Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 Ofarrell St
San Francisco, CA 94115Phone+1 415-833-2000
Education & Training
University of California (San Francisco)Residency, Pediatrics, 1992 - 1995
David Geffen School of Medicine at UCLAClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2025
NM State Medical License 1996 - 1997
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 28 citationsEffect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate ca...Kim N. Chi, Anthony W. Tolcher, Peter P. Lee, P. J. Rosen, Christian Kollmannsberger
Cancer Chemotherapy and Pharmacology. 2013-01-01 - 206 citationsSTAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.Chunyan Zhang, Chanyu Yue, Andreas Herrmann, Jieun Song, Colt Egelston
Cell Metabolism. 2020-01-07 - 364 citationsIsolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.Cassian Yee, Peter A. Savage, Peter P. Lee, Mark M. Davis, Philip D. Greenberg
Journal of Immunology. 1999-02-15
Press Mentions
Stand up to Cancer Awards 5 'Phillip A. Sharp Innovation in Collaboration' GrantsMay 2nd, 2019
Lakehead University Hosting Discussion on the Impact of Mercury ContaminationMarch 1st, 2017
Grant Support
- Interplay Between Cancer And Immune Cells On Targeted TherapyNational Cancer Institute2008–2012
- Immune Profile Analysis Of Tumor-Draining Lymph Nodes In Breast CancerNational Cancer Institute2007–2011
- Characterization Of Tumor Specific T Cells In MelanomaNational Cancer Institute2001–2005
- Endogenous T Cell Responses To MelanomaNational Cancer Institute1999–2001
- Endogenous T Cell Responses To LeukemiaNational Cancer Institute1997–1998
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
